Literature DB >> 18845559

Induction of intestinalization in human esophageal keratinocytes is a multistep process.

Jianping Kong1, Hiroshi Nakagawa, Brandon K Isariyawongse, Shinsuke Funakoshi, Debra G Silberg, Anil K Rustgi, John P Lynch.   

Abstract

Barrett's esophagus (BE) is the replacement of normal squamous esophageal mucosa with an intestinalized columnar epithelium. The molecular mechanisms underlying its development are not understood. Cdx2 is an intestine-specific transcription factor that is ectopically expressed in BE, but its role in this process is unclear. Herein, we describe a novel cell culture model for BE. Retroviral-mediated Cdx2 expression in immortalized human esophageal keratinocytes [EPC-human telomerase reverse transcriptase (hTERT)] could transiently be established but not maintained and was associated with a reduction in cell proliferation. Coexpression of cyclin D1, but not a dominant-negative p53, rescued proliferation in the Cdx2-expressing cells. Cdx2 expression in the EPC-hTERT.D1 cells decreased cell proliferation but did not induce intestinalization. We investigated for other treatments to enhance intestinalization and found that acidic culture conditions uniformly killed EPC-hTERT.D1.Cdx2 cells. However, treatment with 5-aza-2-deoxycytidine (5-AzaC) to demethylate epigenetically silenced genes did appear to be tolerated. Multiple Cdx2 target genes, markers of intestinal differentiation and markers of BE, were induced by this 5-AzaC treatment. More interestingly, the expression level of several of these genes was enhanced only in the EPC-hTERT.D1-Cdx2 cells treated with 5-AzaC. Two of these, SLC26a3/DRA (downregulated in adenoma) and Na+/H+ exchanger 2 (NHE2), were not previously known to be elevated in BE; however, we confirmed their elevation in BE tissue samples. 5-AzaC treatment also induced cell senescence, even at low doses. We conclude that ectopic proliferation signals, alterations in epigenetic gene regulation and the inhibition of tumor suppressor mechanisms are required for Cdx2-mediated intestinalization of human esophageal keratinocytes in BE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845559      PMCID: PMC2722140          DOI: 10.1093/carcin/bgn227

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  63 in total

Review 1.  Development of the human gastrointestinal tract: twenty years of progress.

Authors:  R K Montgomery; A E Mulberg; R J Grand
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

2.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

Authors:  J Winer; C K Jung; I Shackel; P M Williams
Journal:  Anal Biochem       Date:  1999-05-15       Impact factor: 3.365

3.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium.

Authors:  D G Silberg; E E Furth; J K Taylor; T Schuck; T Chiou; P G Traber
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

5.  An intestine-specific homeobox gene regulates proliferation and differentiation.

Authors:  E Suh; P G Traber
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

6.  Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation.

Authors:  I Moscoso; A Centeno; E López; J I Rodriguez-Barbosa; I Santamarina; P Filgueira; M J Sánchez; R Domínguez-Perles; G Peñuelas-Rivas; N Domenech
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

7.  Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice.

Authors:  F Beck; K Chawengsaksophak; P Waring; R J Playford; J B Furness
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Cell Sci       Date:  1997-03       Impact factor: 5.285

9.  Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.

Authors:  S P Regalado; Y Nambu; M D Iannettoni; M B Orringer; D G Beer
Journal:  Mol Carcinog       Date:  1998-07       Impact factor: 4.784

10.  Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT.

Authors:  P Boukamp; J Chen; F Gonzales; P A Jones; N E Fusenig
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  21 in total

1.  Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20.

Authors:  Jianping Kong; Mary Ann S Crissey; Antonia R Sepulveda; John P Lynch
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  A surprise cell of origin for Barrett's esophagus.

Authors:  Urs von Holzen; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2012-06-01       Impact factor: 4.742

Review 3.  New models of neoplastic progression in Barrett's oesophagus.

Authors:  Kirill Pavlov; Carlo C Maley
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

Review 4.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

5.  Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress.

Authors:  Jianping Kong; Kelly A Whelan; Dorottya Laczkó; Brendan Dang; Angeliz Caro Monroig; Ali Soroush; John Falcone; Ravi K Amaravadi; Anil K Rustgi; Gregory G Ginsberg; Gary W Falk; Hiroshi Nakagawa; John P Lynch
Journal:  Mol Carcinog       Date:  2015-09-16       Impact factor: 4.784

6.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

Review 7.  Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM.

Authors:  Ramon U Jin; Jason C Mills
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

8.  Modeling Esophagitis Using Human Three-Dimensional Organotypic Culture System.

Authors:  Dorottya Laczkó; Fang Wang; F Bradley Johnson; Nirag Jhala; András Rosztóczy; Gregory G Ginsberg; Gary W Falk; Anil K Rustgi; John P Lynch
Journal:  Am J Pathol       Date:  2017-06-13       Impact factor: 4.307

9.  Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Authors:  Aaron Goldman; Hwu Dau Rw Chen; Heather B Roesly; Kimberly A Hill; Margaret E Tome; Bohuslav Dvorak; Harris Bernstein; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-02       Impact factor: 4.052

10.  Cox2 and β-catenin/T-cell factor signaling intestinalize human esophageal keratinocytes when cultured under organotypic conditions.

Authors:  Jianping Kong; Mary Ann S Crissey; Douglas B Stairs; Antonia R Sepulveda; John P Lynch
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.